|Mr. John Simard||Founder, Pres, CEO & Chairman||4.67M||N/A||1962|
|Dr. Sushma Shivaswamy Ph.D.||Chief Scientific Officer||381.24k||N/A||1978|
|Ms. Angela Hu||Director of Fin., Principal Financial & Accounting Officer and Financial Controller||N/A||N/A||1984|
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBiotech Inc.’s ISS Governance QualityScore as of September 1, 2023 is 8. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 5; Compensation: 9.